Not FDA-approved · not lawfully compounded

Can you buy CagriSema? What it costs, and what to take instead

Last updated

Not on sale yet: semaglutide, the closest medicine you can buy now

  • Lowest FDA-approved

    NovoCare (Novo Nordisk)

    $149/30 days · about $149 per 30 days

  • Lowest compounded on a monthly plan, not FDA-approved

    Collective

    $59/mo + $199/yr membership · about $76 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

CagriSema has no lawful US price: it is under FDA review and not yet approved, so no pharmacy can fill a prescription for it, and the FDA says: "Retatrutide and cagrilintide cannot be used in compounding under federal law." The closest medicine you can buy now is semaglutide, a GLP-1 receptor agonist; CagriSema is an amylin analog (cagrilintide) plus GLP-1 agonist (semaglutide). Wegovy, FDA-approved semaglutide, costs $199/28 days, through Dec 31, 2026 at 0.25 mg and $349/28 days at 2.4 mg without insurance at Amazon Pharmacy and NovoCare (Novo Nordisk), checked Nov 11, 2026 on pharmacy.amazon.com and novocare.com. Compounded semaglutide, which is not FDA-approved, starts at $59/mo + $199/yr membership (about $76 a month over a year with the membership) at Collective on a monthly plan.

Questions

Buying CagriSema

How much does CagriSema cost per month in the US?

It has no lawful price yet: CagriSema is under FDA review and not yet approved, and the FDA says: "Retatrutide and cagrilintide cannot be used in compounding under federal law." A product sold as CagriSema today is not an approved or lawfully compounded medicine. Wegovy, FDA-approved semaglutide, costs $199/28 days, through Dec 31, 2026 at 0.25 mg and $349/28 days at 2.4 mg without insurance at Amazon Pharmacy and NovoCare (Novo Nordisk), checked Nov 11, 2026 on pharmacy.amazon.com and novocare.com. Compounded semaglutide, which is not FDA-approved, starts at $59/mo + $199/yr membership (about $76 a month over a year with the membership) at Collective on a monthly plan. Every compounded semaglutide price

Can I buy compounded CagriSema?

No lawful pharmacy can make it: "Retatrutide and cagrilintide cannot be used in compounding under federal law." The FDA's advice: "Patients should obtain a prescription from their doctor and fill the prescription at a state-licensed pharmacy." FDA: concerns with unapproved GLP-1 drugs used for weight loss

CagriSema vs semaglutide: which works better?

In separate trials, not a head-to-head comparison: CagriSema 2.4 mg / 2.4 mg weekly, a mean weight loss of 20.4% in REDEFINE-1 (Phase 3) (novonordisk.com/news-and-media/news-and-ir-materials/news-details.html), and semaglutide (Wegovy) 2.4 mg weekly, 14.9% at 68 wks in STEP 1 (nejm.org/doi/full/10.1056/NEJMoa2032183). CagriSema is an amylin analog (cagrilintide) plus GLP-1 agonist (semaglutide); semaglutide is a GLP-1 receptor agonist, and only semaglutide can be bought today. CagriSema: every trial, with its source

What can I take instead of CagriSema now?

With a prescription: semaglutide, FDA-approved as Wegovy, or compounded (not FDA-approved). Compounded semaglutide, which is not FDA-approved, starts at $59/mo + $199/yr membership (about $76 a month over a year with the membership) at Collective on a monthly plan. Wegovy's cash price at each dose, with its conditions, is on its price page. A prescriber decides which fits you. The cheapest semaglutide without insurance

GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.

This page quotes the FDA and published trials; it is not medical advice, and a prescriber decides which medicine fits you. GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.